Pooled mutation analysis for the NP28673 and NP28761 studies of alectinib in ALK+ non-small-cell lung cancer (NSCLC).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Oscar Puig, James Chih-Hsin Yang, Sai-Hong Ignatius Ou, Alberto Chiappori, Bo H Chao, Chandra Prakash Belani, Alexander I. Spira, Alessandra Bearz, Michael Duruisseaux, John Allard, Fabian Birzele, Frederic Boisserie, Ulrika Lonngren, Walter Bordogna, Daniel M. Klass, Aaron M. Newman, Ali Hassan Zeaiter, Alice Tsang Shaw
Institutions: National Taiwan University Hospital, University of California, Irvine, Moffitt Cancer Center, The Ohio State University, Penn State Cancer Institute, Virginia Cancer Specialists, Centro di Riferimento Oncologico, Centre Hospitalier Universitaire de Grenoble, Roche (Switzerland), Roche (United Kingdom), Stanford Medicine, Stanford University, Massachusetts General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2531779599